AGREEMENT AND PLAN OF MERGER by and among MOTIF BIOSCIENCES INC., MOTIF BIO PLC, MOTIF ACQUISITION SUB INC., and STEPHEN AUSTIN, as Motif UK Sole Shareholder dated as of March 27, 2015Agreement and Plan of Merger • July 21st, 2016 • Motif Bio PLC • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER BY AND AMONG NUPRIM, INC., (a Maryland corporation) NUPRIM SHAREHOLDERS, MOTIF BIOSCIENCES INC., (a Delaware corporation) AND R. MICHAEL FLOYD AS NUPRIM SHAREHOLDERS’ REPRESENTATIVE DATED AS OF December 31, 2014Agreement and Plan of Merger • July 21st, 2016 • Motif Bio PLC • Pharmaceutical preparations • Delaware
This AGREEMENT AND PLAN OF MERGER (together with all Schedules and Exhibits, this “Agreement”), dated as of December 31, 2014, is entered into by and among Motif Biosciences Inc., a Delaware corporation (“Motif”), Nuprim, Inc., a Maryland corporation (“Nuprim”), and each of R. Michael Floyd, Khalid Islam, Brad Spellberg, and Sergio Lociuro (collectively the “Nuprim Shareholders” and each a “Nuprim Shareholder”) as the shareholders of Nuprim. Additionally, this Agreement is joined by R. Michael Floyd in his representative capacity as Nuprim Shareholders’ Representative. Motif, Nuprim, Nuprim Shareholders and Nuprim Shareholders’ Representative are each referred to herein as a “Party” and collectively as, the “Parties”.
